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173 Upregulated caspase activity in cystic ﬁbrosis respiratory
epithelium − a link to increased apoptosis?
Q. Chen1, S. Weldon1, D. Quinn1, J.S. Elborn1, C. Taggart1. 1Queen’s University
Belfast, Centre for Infection and Immunity, Belfast, United Kingdom
Objectives: Cystic Fibrosis (CF) lung disease is characterised by chronic infection
and inﬂammation. Although infection by a variety of microorganisms is a major
contributing factor to the sustained inﬂammatory response observed in the CF lung,
much debate remains regarding the existence of a dysregulated innate response
in respiratory epithelium expressing mutant CFTR. Recent studies suggest that
CF airway epithelial cells undergo abnormal apoptosis which can exacerbate lung
disease in CF patients resulting in the loss of functional airway epithelial cells.
Methods: In this study we have addressed the impact of CFTR mutation (F508del)
on caspases associated with apoptotic signalling pathways using two CF cell lines
(CFBEs and CFTEs) and corresponding non-CF cell lines (HBEs and HTEs). We
have demonstrated that basal caspase-3 and caspase-8 activity are signiﬁcantly
elevated in the CF cell lines compared to non-CF cell lines. We have also shown that
incubation of the CFTR Inh-172 inhibitor with the non-CF cells leads to increased
caspase activity in these cells. However, we have been unable to show increased
cell death either by Cell Death ELISA or by TUNEL in CF cells versus non-CF
cells.
Conclusion: These ﬁndings suggest that other factors in CF cells may regulate
caspase-3/-8 activity in such a way as to inhibit any downstream (DNA cleavage)
effects of these proteases. However, it is also possible that elevated caspase activity
may contribute to other non-apoptotic effects in these cells including elevated
inﬂammatory responses.
174* Hypoxia ampliﬁes NF-úB dependent signaling in response
to Pseudomonas aeruginosa and prevents internalisation in
pulmonary epithelial cells
B. Schaible1, C.T. Taylor1, K. Schaffer2. 1University College Dublin, Conway
Institute, Dublin, Ireland; 2St. Vincent’s University Hospital, Clinical Microbiology,
Dublin, Ireland
Pseudomonas aeruginosa (P. aeruginosa) is the predominant bacterial pathogen in
Cystic Fibrosis (CF). Within the CF lung P. aeruginosa grows in a hypoxic bioﬁlm
causing chronic infection and inﬂammation. In this study we have investigated
the effects of hypoxia on the activity of the pro-inﬂammatory transcription factor
NF-úB and downstream consequences in pulmonary epithelial cells in response to
P. aeruginosa.
Incubation of A549 lung epithelial cells with heat inactivated P. aeruginosa
increased nuclear NF-úB (p65) protein level and NF-úB transcription factor activity
in a manner that was profoundly ampliﬁed by epithelial cell hypoxia (1% oxygen).
Stimulation of the innate immune response to bacteria in pulmonary epithelial cells
is largely mediated by three toll-like receptors (TLR2, TLR4 and TLR5) which sense
conserved bacterial structures on the apical cell surface. NF-úB activation of cells
with TLR speciﬁc agonists suggests a selective enhancement of TLR5 signaling
under hypoxic conditions as the TLR5 ligand ﬂagellin increased NF-úB level in a
manner which was ampliﬁed by hypoxia. In an in vitro infection model, hypoxia
signiﬁcantly diminished internalisation of P. aeruginosa into pulmonary epithelial
cells (along with decreased cell toxicity compared to normoxic conditions).
These data indicate that microenvironmental hypoxia is a major determinant of
the pulmonary epithelial innate immune response during P. aeruginosa infection.
Further investigations of signaling molecules participating in this response will
reveal new targets for anti-infective therapy in CF.
175 TGFb1 genotypes in correlation to TGFb1 in induced sputum and
serum in cystic ﬁbrosis (CF)
S. Schmitt-Grohe1, F. Schreiner1, L. van den Boom1, D. N’Gampolo1,
O. Eickmeier2, R. Schubert2, I. Broeckart1, S. Zielen1, M.J. Lentze1.
1Universita¨tsklinikum Bonn, Zentrum fu¨r Kinderheilkunde, Bonn, Germany;
2Goethe University Hospital, Pediatric Pulmonary, Frankfurt, Germany
Aim: To assess the relationship between TGFb1 genotypes, TGFb1 (in induced
sputum and serum) and lung disease.
Methods: 23 patients delta F 508 homozygous [median age 24 y, m/f 13/10, BMI
20, 96 kg/m2, Shwachman score 75, FEV1(%) 84] were examined. TGFb1 was
assessed in serum and induced sputum (IS) by an ELISA kit (R&D Systems,
Wiesbaden, Germany). Genotyping was performed for the TGFb1 C-509T and
T+869C genotype utilizing techniques previously described (Collaco et al. 2008).
Results: TGFb1 mutants (C-509T mutant/wildtype n = 9/14; T+869C mu-
tant/wildtype (7/16) had no inﬂuence on levels of TGFb1 in IS (C-509T
mutant/wildtype median 80.2/71.8 pg/ml, n.s; T+869C mutant/wildtype median
80.2/71.75 pg/ml, n.s) and serum (C-509T mutant/wildtype median 35.8/34.9 pg/ml,
n.s; T+869C mutant/wildtype median 35.8/34.9 pg/ml, n.s) nor on leukocytes in
IS (C-509T mutant/wildtype median 651/495/ml, n.s; T+869C mutant/wildtype
median 651.25/495/ml, n.s) and in EDTA blood (C-509T mutant/wildtype median
6325/6990 pg/ml, n.s; T+869C mutant/wildtype median 6325/6990/ml, n.s), lung
function resp FEV1(%) (C-509T mutant/wildtype median 68.6/86.7%, n.s; T+869C
mutant/wildtype median 60.3/86.66 %, n.s) or BMI (C-509T mutant/wildtype
median 21.9/19.2 pg/ml, n.s; T+869C mutant/wildtype median 22.41/19.52, n.s).
Conclusion: Regardless of genotype there is no difference for TGFb1 in IS and
serum as well as for lung or BMI function in a small cohort. This might be
explained by the following TGFb is activated by different pathways e.g. avb6-
mediated activation appears to be absolutely dependent on direct cell-cell contact
and does not release any diffusible free TGFb (Munger et al. 1999).
176 A role of host cytosolic phospholipase A2 in acute lung infection
by Pseudomonas aeruginosa
Y. Wu1, D. Leduc1, V. Balloy1, M. Chignard1, L. Touqui1. 1Institut Pasteur,
De´fense Inne´e et Inﬂammation, Paris, France
Pseudomonas aeruginosa (Pa) induces lung injury in pulmonary diseases including
cystic ﬁbrosis (CF). Pa is known to activate the host cytosolic phospholipase
A2a (cPLA2a), which catalyzes the release of arachidonic acid (AA) and its
metabolite prostaglandin E2 (PGE2). However, the mechanisms and role of cPLA2a
in Pa-induced lung injury have not been investigated. Here, we investigated lung
inﬂammation and mortality in mouse model of pulmonary infection by a laboratory
(PAK) and a clinical strain (CHA) of Pa. CHA was revealed to be more potent than
PAK in inducing lung inﬂammation and animal mortality. cPLA2a-null mutation
attenuated animal mortality caused by both PAK and CHA but failed to reduce lung
inﬂammation or bacterial proliferation. CHA infection led to increased mortality in
CF compared to non-CF mice. Pharmacological inhibition of cPLA2a attenuated
CHA-induced CF mice mortality without interfering with lung inﬂammation. CHA
triggered AA and PGE2 release and cPLA2a phosphorylation in lung epithelial
cell line A549 at higher levels than PAK. This was accompanied by increased p38
MAPK phosphorylation. Inhibition of cPLA2a and p38 attenuated both PAK- and
CHA-induced AA and PGE2 release by A549 cells. However, inhibition of cPLA2a
had no effect on IL-8 secretion. CHA caused LDH release by A549 cells at higher
extent than PAK both of which were reduced by cPLA2a inhibitors. Together these
ﬁnding suggest that cPLA2a plays a role in Pa-induced lethality in pulmonary
infection models including CF. This effect seems to occur via a process related
to cPLA2a-induced toxicity independently from lung inﬂammation and bacterial
proliferation.
